RT Journal Article T1 Context-dependent impact of RAS oncogene expression on cellular reprogramming to pluripotency A1 Ferreirós, Alba A1 Pedrosa, Pablo A1 Silva Álvarez, Sabela da A1 Triana Martínez, Francisco A1 Vilas Martínez, Jéssica María A1 Picallos Rabina, Pilar A1 González, Patricia A1 Gómez, María A1 Li, Han A1 García-Caballero Parada, Tomás A1 González Barcia, Miguel A1 Vidal Figueroa, Anxo A1 Collado Rodríguez, Manuel K1 Ras K1 Oncogenes K1 Cell reprogramming K1 iPSC K1 Cell plasticity AB Induction of pluripotency in somatic cells with defined genetic factors has been successfully used to investigate the mechanisms of disease initiation and progression. Cellular reprogramming and oncogenic transformation share common features; both involve undergoing a dramatic change in cell identity, and immortalization is a key step for cancer progression that enhances reprogramming. However, there are very few examples of complete successful reprogramming of tumor cells. Here we address the effect of expressing an active oncogene, RAS, on the process of reprogramming and found that, while combined expression with reprogramming factors enhanced dedifferentiation, expression within the context of neoplastic transformation impaired reprogramming. RAS induces expression changes that promote loss of cell identity and acquisition of stemness in a paracrine manner and these changes result in reprogramming when combined with reprogramming factors. When cells carry cooperating oncogenic defects, RAS drives cells into an incompatible cellular fate of malignancy. PB Cell Press YR 2019 FD 2019 LK http://hdl.handle.net/10347/21396 UL http://hdl.handle.net/10347/21396 LA eng NO Ferreirós, A., Pedrosa, P., Da Silva-Álvarez, S., Triana-Martínez, F., Vilas, J., Picallos-Rabina, P., González, P., Gómez, M., Li, H., García-Caballero, T., González-Barcia, M., Vidal, A. and Collado, M., 2019. Context-Dependent Impact of RAS Oncogene Expression on Cellular Reprogramming to Pluripotency. Stem Cell Reports, 12(5), pp.1099-1112. NO A.F. is an FPU predoctoral fellow from MECD; P.P. and J.M.V. are predoctoral fellows from Xunta de Galicia; F.T.-M. is a postdoctoral fellow from CONACYT (cvu 268632). M.C. is a ‘‘Miguel Servet II’’ investigator (CPII16/00015). Work in the laboratory of M.C. is funded by an ISCIII and EU-FEDER grant (PI14/00554). Work in the laboratory of A.V. is funded by Xunta de Galicia (ED431B 2016) and MINECO (MAT2017-89678-R; cofinanced with FEDER Funds) DS Minerva RD 23 abr 2026